Efficacy and tolerability of levetiracetam in children aged 10 years and younger: a clinical experience
- 30 April 2004
- Vol. 13 (3) , 142-145
- https://doi.org/10.1016/s1059-1311(03)00193-6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Effect of levetiracetam in refractory childhood epilepsy syndromesEuropean Journal of Paediatric Neurology, 2003
- Clinical experience of marketed Levetiracetam in an epilepsy clinic—a one year follow up studySeizure, 2003
- An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day−1 in adult patients with refractory epilepsySeizure, 2003
- Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapyEpilepsy Research, 2003
- A paradoxical effect of levetiracetam may be seen in both children and adults with refractory epilepsySeizure, 2003
- Levetiracetam in refractory pediatric epilepsy.Journal of Child Neurology, 2002
- Levetiracetam: A new antiepileptic drug for the adjunctive therapy of chronic epilepsyDrugs of Today, 2001
- Antiepileptic Drug‐Induced Worsening of Seizures in ChildrenEpilepsia, 1998
- Proposal for Revised Classification of Epilepsies and Epileptic SyndromesEpilepsia, 1989
- Proposal for Revised Clinical and Electroencephalographic Classification of Epileptic SeizuresEpilepsia, 1981